Physician profile
Ayaz Rasool
NPI 1467561043
$2,031.76
in general payments reported to CMS, 2019-2025
18 companies · $343 in 2025
The $343 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $110 · 2021: $355 · 2022: $234 · 2023: $254 · 2024: $572 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,169.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $531.02 | 2024-2025 | Auvelity |
| Astellas Pharma US INC | $385.49 | 2019-2023 | Myrbetriq |
| Takeda Pharmaceuticals U.S.A., INC. | $230.20 | 2022-2025 | Trintellix |
| Pfizer INC. | $162.62 | 2020-2025 | |
| Abbvie INC. | $150.22 | 2021-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $124.49 | 2022-2024 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $106.41 | 2024-2025 | Rexulti, Abilify Maintena |
| Boston Scientific Corporation | $71.95 | 2020-2021 | |
| Neotract INC. | $44.76 | 2019 | |
| Dentsply Ih Ab | $44.17 | 2023-2024 | Lofric, Lofric |
| Dentsply Ih INC. | $42.52 | 2019-2021 | |
| Alkermes, INC. | $24.54 | 2022 | |
| Telix Pharmaceuticals | $24.44 | 2024 | Illuccix |
| Janssen Pharmaceuticals, INC | $22.86 | 2019 | |
| Idorsia Pharmaceuticals US INC | $20.00 | 2023 | Quviviq |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $17.25 | 2019 | |
| Clarus Therapeutics INC. | $16.29 | 2021 | |
| Endo Pharmaceuticals INC. | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayaz Rasool listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.